Ghent University Academic Bibliography

Advanced

Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study

Jean-Luc Van Laethem, Pascal Hammel, Françoise Mornex, David Azria, Geertjan Van Tienhoven, Philippe Vergauwe, Marc Peeters UGent, Marc Polus, Marleen Praet UGent and Murielle Mauer, et al. (2010) JOURNAL OF CLINICAL ONCOLOGY. 28(29). p.4450-4456
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
CHEMORADIATION, PANCREATICODUODENECTOMY, LONG-TERM SURVIVAL, NUCLEOSIDE TRANSPORTER 1, CONCURRENT RADIATION, CONTROLLED-TRIAL, HEAD CARCINOMA, ADENOCARCINOMA, CHEMOTHERAPY, RADIOTHERAPY
journal title
JOURNAL OF CLINICAL ONCOLOGY
J. Clin. Oncol.
volume
28
issue
29
pages
4450 - 4456
Web of Science type
Article
Web of Science id
000282643600033
JCR category
ONCOLOGY
JCR impact factor
18.97 (2010)
JCR rank
4/181 (2010)
JCR quartile
1 (2010)
ISSN
0732-183X
DOI
10.1200/JCO.2010.30.3446
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
1193713
handle
http://hdl.handle.net/1854/LU-1193713
date created
2011-03-22 11:02:03
date last changed
2011-05-31 18:20:12
@article{1193713,
  author       = {Van Laethem, Jean-Luc and Hammel, Pascal and Mornex, Fran\c{c}oise and Azria, David and Van Tienhoven, Geertjan and Vergauwe, Philippe and Peeters, Marc and Polus, Marc and Praet, Marleen and Mauer, Murielle and Collette, Laurence and Budach, Volker and Lutz, Manfred and Van Cutsem, Eric and Haustermans, Karin},
  issn         = {0732-183X},
  journal      = {JOURNAL OF CLINICAL ONCOLOGY},
  keyword      = {CHEMORADIATION,PANCREATICODUODENECTOMY,LONG-TERM SURVIVAL,NUCLEOSIDE TRANSPORTER 1,CONCURRENT RADIATION,CONTROLLED-TRIAL,HEAD CARCINOMA,ADENOCARCINOMA,CHEMOTHERAPY,RADIOTHERAPY},
  language     = {eng},
  number       = {29},
  pages        = {4450--4456},
  title        = {Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study},
  url          = {http://dx.doi.org/10.1200/JCO.2010.30.3446},
  volume       = {28},
  year         = {2010},
}

Chicago
Van Laethem, Jean-Luc, Pascal Hammel, Françoise Mornex, David Azria, Geertjan Van Tienhoven, Philippe Vergauwe, Marc Peeters, et al. 2010. “Adjuvant Gemcitabine Alone Versus Gemcitabine-based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: a Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study.” Journal of Clinical Oncology 28 (29): 4450–4456.
APA
Van Laethem, J.-L., Hammel, P., Mornex, F., Azria, D., Van Tienhoven, G., Vergauwe, P., Peeters, M., et al. (2010). Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study. JOURNAL OF CLINICAL ONCOLOGY, 28(29), 4450–4456.
Vancouver
1.
Van Laethem J-L, Hammel P, Mornex F, Azria D, Van Tienhoven G, Vergauwe P, et al. Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study. JOURNAL OF CLINICAL ONCOLOGY. 2010;28(29):4450–6.
MLA
Van Laethem, Jean-Luc, Pascal Hammel, Françoise Mornex, et al. “Adjuvant Gemcitabine Alone Versus Gemcitabine-based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: a Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study.” JOURNAL OF CLINICAL ONCOLOGY 28.29 (2010): 4450–4456. Print.